Source: European Medicines Agency (EU) Publisher: Desma GmbH, Peter-Sander-Str. 41b, 55252, Mainz-Kastel, Germany, Tel: +49 (0) 6134 21079 0, Fax: +49 (0) 6134 21079 24
Akineton 5 mg – solution for injection.
| Pharmaceutical Form |
|---|
|
Clear, colourless solution for injection, free from suspended matter. pH 4.8-5.8 |
Active substance: Biperiden Lactate.
1 ampoule of 1 ml solution for injection contains 5 mg Biperiden Lactate equivalent to 3.9 mg Biperiden.
Excipient with known effect: less than 1 mmol sodium (sodium lactate).
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Biperiden |
Biperiden is a predominantly centrally acting anti-cholinergic. It has a peripheral effect, which is low in comparison to atropine. Biperiden binds competitively to peripheral and central muscarinic receptors (primarily M1). |
| List of Excipients |
|---|
|
Sodium-(RS)-lactate |
5 white-glass ampoules (type I) of 1 mlsolution for injection.
50 (10x5) white-glass ampoules (type I) of 1 ml solution for injection.
Not all pack sizes may be marketed.
Desma GmbH, Peter-Sander-Str. 41b, 55252, Mainz-Kastel, Germany, Tel: +49 (0) 6134 21079 0, Fax: +49 (0) 6134 21079 24
| Drug | Countries | |
|---|---|---|
| AKINETON | Austria, Brazil, Cyprus, Germany, Ecuador, Estonia, Spain, Finland, France, Croatia, Ireland, Japan, Lithuania, Mexico, Netherlands, Poland, Turkey |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
